SINGAPORE, Oct. 25, 2021 /PRNewswire/ -- 10x Genomics
(Nasdaq: TXG), a life sciences leader focused on mastering biology
to advance human health, today marked a major Asia Pacific (APAC) expansion with the grand
opening celebration of its Singapore manufacturing facility and
commercial hub.
The addition of the company's first manufacturing facility
outside the U.S. is part of 10x Genomics' ongoing investments to
integrate and scale its operations network to build a more robust
supply chain and better serve customers globally. The manufacturing
center provides additional capacity for 10x Genomics' leading
portfolio of consumables for single-cell and spatial analysis. The
site also serves as the APAC commercial hub, strengthening the
company's in-region sales, marketing and customer support
capabilities.
10x Genomics' Singapore hub
occupies more than 53,000 square feet of the Solaris@Kallang 164
complex, including state-of-the art, automated production suites
for reagent manufacturing and a fully equipped, Biosafety Level-2
lab for training customers and partners on all 10x Genomics' single
cell and spatial technologies. The site, which began initial
operations in late 2020, also includes a distribution center,
supporting warehouse space and open office areas that encourage
collaboration and teamwork. 10x Genomics currently employs more
than 80 employees in Singapore in
manufacturing, corporate functions and commercial roles.
As 10x Genomics continues to expand its global reach, the
Asia-Pacific region is an
important market for the company, representing 25 percent of global
sales in the first half of 2021.
10x Genomics selected Singapore
as the ideal location for its expansion because of the Singapore government's demonstrated commitment
to the biotechnology industry and business-friendly practices,
world-class manufacturing expertise and strong talent pool.
"Singapore is a global hub for
biotechnology with a thriving innovation ecosystem and strong
research community," said Serge Saxonov, Co-founder and CEO of 10x
Genomics. "We sincerely thank the Economic Development Board of
Singapore for their incredible
support and partnership and the 10x teams in Singapore and California for their tremendous efforts in
bringing this site online. We are thrilled to grow our presence
here and are excited to contribute to Singapore's culture of science and innovation
as we work to fulfill the promise of this Century of Biology."
"10x Genomics' Singapore
manufacturing facility and commercial hub will be a vibrant
addition to our life sciences ecosystem, and we look forward to
continuing our strong partnership with the company. The life
sciences sector is an important pillar of our Healthcare industry
and has a promising growth trajectory. The Economic Development
Board remains committed to supporting innovation and manufacturing
activities in this sector, which will create good jobs and business
opportunities in Singapore," said
Ms. Goh Wan Yee, Senior Vice
President and Head, Healthcare, Singapore Economic Development
Board.
About 10x Genomics
10x Genomics is a life science technology company building
products to interrogate, understand and master biology to advance
human health. The company's integrated solutions include
instruments, consumables and software for analyzing biological
systems at a resolution and scale that matches the complexity of
biology. 10x Genomics products have been adopted by researchers
around the world including in all of the top 100 global research
institutions as ranked by Nature in 2020 based on publications and
all of the top 20 global pharmaceutical companies by 2020 research
and development spend and have been cited in over 2,800 research
papers on discoveries ranging from oncology to immunology and
neuroscience. The company's patent portfolio comprises more than
1,150 issued patents and patent applications.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange
Commission, its website (www.10xgenomics.com), press releases,
public conference calls, public webcasts and its social media
accounts as means of disclosing material non-public information and
for complying with its disclosure obligations under Regulation
FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original
content:https://www.prnewswire.com/news-releases/10x-genomics-celebrates-opening-of-singapore-manufacturing-and-commercial-hub-301407271.html
SOURCE 10x Genomics, Inc.